The stakes are considerable. Campylobacter is a leading bacterial cause of food-borne illness worldwide, and poultry meat is the dominant route of human exposure, whether through undercooked products or cross-contamination in the kitchen. In commercial broiler flocks, colonisation rates commonly range from about 55 percent to 100 percent, meaning the chicken intestinal tract functions as a vast reservoir of the pathogen. At slaughter, leakage of caecal contents can contaminate carcass surfaces, amplifying risk along the entire food chain. Because the caecal load of Campylobacter at the end of rearing is the strongest single predictor of carcass contamination, interventions that act inside the living bird have long been a priority for food-safety researchers.

The new analysis, conducted by Muhammet Kuddusi Erhan of Ağrı İbrahim Çeçen University in Türkiye, searched PubMed, Scopus and Google Scholar for controlled in vivo broiler trials published between January 2000 and July 2025. Following PRISMA 2020 guidelines, the review identified twelve eligible studies, eleven of which contributed fifteen separate comparisons to the quantitative syntheses. The author used random-effects models, taking the mean difference in log10 colony-forming units per gram of caecal contents as the effect measure for colonisation, and the standardised mean difference for growth performance, with pre-planned subgroup, dose-response and sensitivity analyses layered on top.

The headline result is striking. Across all routes of administration, caprylic acid supplementation reduced caecal C. jejuni loads by a pooled 1.46 log10 CFU per gram, a statistically significant reduction with a 95 percent confidence interval running from 2.50 to 0.41. But the pooled figure concealed enormous heterogeneity between studies, with an I-squared value of 88.1 percent, indicating that the trials were estimating genuinely different underlying effects rather than a single common one. Locating the source of that inconsistency turned out to be the most scientifically valuable part of the entire exercise.

When the comparisons were stratified by route of administration, the picture snapped into focus. In-feed application reduced colonisation by a pooled 2.68 log10 CFU per gram, with only moderate residual heterogeneity, whereas delivery via drinking water produced essentially no detectable effect at all. The formal test for subgroup differences was unambiguous, and the fall in heterogeneity from 88.1 percent overall to 39.0 percent within the in-feed subgroup identified the delivery matrix as the principal determinant of efficacy. Within the in-feed trials, 0.7 percent caprylic acid given for three to ten days cut caecal counts by 2.0 to 3.9 log10 units in three independent experiments, spanning both prophylactic use in young chicks and therapeutic use in market-aged birds.

The mechanism behind this route dependence is biologically plausible. Caprylic acid is bactericidal against C. jejuni in vitro at low millimolar concentrations, inserting into and disrupting bacterial membranes, interfering with the electron transport chain, lowering intracellular pH and inhibiting key metabolic enzymes. Feed, however, provides a lipophilic, slow-release matrix in which the undissociated fatty acid can survive passage through the upper gastrointestinal tract. Aqueous formulations, by contrast, appear to be rapidly absorbed by enterocytes before ever reaching the caeca, where C. jejuni colonises the mucus layer and is shielded from fatty acid activity. Consistent with this interpretation, raising the water-borne concentration thirty-two-fold produced no graded response whatsoever, suggesting the limiting step is survival en route rather than the quantity administered.

Equally important is what the analysis found about growth. Across nine comparisons, caprylic acid had no overall effect on growth performance, with a pooled standardised mean difference of +0.16 that was statistically indistinguishable from zero. This growth neutrality is what makes the compound economically viable as a pathogen-reduction tool. But the dose-response analysis revealed a clear ceiling. In-feed concentrations between roughly 0.35 percent and 0.875 percent produced consistent reductions of 2.2 to 3.6 log10 units, while higher concentrations became both weaker on average and markedly less reproducible. At 1.4 percent of feed, body weight was significantly depressed, with feed consumption falling steadily across the dose series. Palatability, it seems, imposes an upper practical limit before any pharmacological ceiling is reached, although reduced intake alone does not fully explain the loss of antimicrobial efficacy, since total caprylic acid consumption still rose with dose.

The author is candid about the limitations of the evidence base. Funnel-plot asymmetry was statistically significant, which in principle signals publication bias, but in this dataset the asymmetry maps precisely onto the feed-versus-water contrast: the imprecise, strongly negative comparisons are the in-feed trials, and the precise, near-null comparisons are the drinking-water trials. Genuine subgroup heterogeneity can generate funnel asymmetry as readily as selective publication, and with only six colonisation comparisons no statistical procedure can adjudicate between the two explanations. The pooled estimate of 1.46 log10 units should therefore be read as an upper bound on the true average in-feed effect. A leave-one-out analysis showed the direction of the effect was robust to the removal of any single comparison, though its statistical significance depended marginally on the largest trial. The apparently positive growth responses to caprylic acid blends also warrant caution, since in those comparisons the compound’s contribution could not be separated from that of other bioactive ingredients.

Why does the magnitude matter so much? Quantitative risk assessment indicates that a two-log reduction in carcass contamination would reduce the incidence of human campylobacteriosis associated with chicken meals roughly thirty-fold. The in-feed effect documented here, averaging 2.68 log10 units, comfortably exceeds that threshold, which is why the author argues that caprylic acid deserves a place within integrated Campylobacter control strategies for producers seeking antibiotic-free alternatives. The analysis also suggests that micro-encapsulated or otherwise protected formulations, which prolong the presence of fatty acids in the lower gut, deserve direct examination, and that future work should explore combinations with competitive exclusion cultures, bacteriophages or vaccination.

The broader significance of the study lies in its framing. Rather than treating antimicrobial efficacy and growth performance as unrelated endpoints, the review evaluates caprylic acid explicitly as a product-quality intervention, in which microbiological safety and zootechnical performance are assessed jointly. An additive that lowers pathogen load at the cost of impaired growth, or that improves growth without any food-safety benefit, has limited practical value. By converging on the same recommendation from both directions, an effective in-feed range of approximately 0.35 to 0.875 percent that delivers the antimicrobial benefit without a measurable productivity cost, the analysis offers the poultry industry something it has rarely had on this question: a quantitatively grounded, honestly caveated prescription. As antibiotic growth promoters remain banned in the European Union and increasingly restricted elsewhere, evidence of this kind may prove essential to making antibiotic-free poultry production both safer and commercially sustainable.

Subject of Research: Effects of dietary caprylic acid on Campylobacter jejuni colonisation and growth performance in broiler chickens

Article Title: Dietary caprylic acid, Campylobacter jejuni colonisation and product quality in broilers: a systematic review and meta-analysis

Article References: Dietary caprylic acid, Campylobacter jejuni colonisation and product quality in broilers: a systematic review and meta-analysis. (n.d.). https://doi.org/10.5194/aab-69-477-2026

Image Credits: AI Generated

DOI: 10.5194/aab-69-477-2026

Keywords: caprylic acid, Campylobacter jejuni, broiler chickens, food safety, meta-analysis, feed additives, medium-chain fatty acids, poultry production, antibiotic-free, dose-response, gut microbiology, zoonoses

The methodology behind the analysis reflects the modern standards of evidence synthesis. The research team searched MEDLINE through PubMed, Embase, Scopus, and Web of Science from database inception to July 2026, casting a wide net for observational studies that evaluated laboratory-confirmed enteric infections against stunting outcomes in children. Nineteen studies passed the quality threshold for the qualitative synthesis, and fourteen contributed effect estimates to the quantitative meta-analysis. The authors followed the PRISMA 2020 reporting guidelines, pooled odds ratios using random-effects models, and assessed risk of bias with the Newcastle–Ottawa Scale. Certainty of evidence was judged using the GRADE framework, the same structured approach that underpins World Health Organization guideline development. This combination of transparent searching, formal bias assessment, and pre-specified subgroup analyses gives the review a methodological rigor that many entries in the stunting literature have lacked.

The headline number deserves unpacking. An odds ratio of 1.94 means that children with laboratory-confirmed enteric infections had roughly 94 percent higher odds of being stunted, defined as height-for-age more than two standard deviations below the reference median, compared with children without such infections. That is a substantial association in a field where effect estimates often hover close to unity. But the pooled figure came with an I-squared statistic of 85.6 percent, indicating that more than eight-tenths of the variability among studies reflected real differences between populations and methods rather than random noise. In practical terms, the pooled odds ratio describes an average of a highly heterogeneous body of evidence, and the authors were careful not to oversell it. Heterogeneity of this magnitude is common in observational meta-analyses of infection and nutrition, where study settings range from urban slums to rural highlands and diagnostic tools range from microscopy to multiplex PCR.

To probe that heterogeneity, the team conducted pre-specified subgroup analyses across pathogen domains: bacterial, viral, protozoal, helminthic, and non-specific parasitic infections. The most consequential finding of the review may be what did not emerge. Despite wide differences in the biology of these organisms, the associations with stunting were broadly comparable across domains, with no statistically significant differences between pathogen groups. Bacteria such as enteroaggregative Escherichia coli, viruses such as rotavirus, protozoa such as Giardia and Cryptosporidium, and soil-transmitted helminths all appeared to leave children at similar elevated risk of growth faltering. The authors interpret this convergent pattern as evidence that multiple enteric pathogens may impair child growth through shared biological pathways rather than through pathogen-specific mechanisms.

That interpretation aligns with two decades of research into environmental enteric dysfunction, a subclinical condition of the small intestine that has become a central hypothesis in child growth biology. Repeated exposure to fecal pathogens is thought to provoke chronic mucosal inflammation, villous atrophy, increased intestinal permeability, and malabsorption, collectively blunting the child’s ability to convert food into linear growth. Studies cited in the review, including the Environmental Enteric Dysfunction Biopsy Initiative and work linking the condition to carnitine deficiency and altered fatty acid oxidation, describe a gut that is chronically inflamed and metabolically compromised even in children who never present with overt diarrhea. Chronic inflammation also suppresses the growth hormone–insulin-like growth factor-1 axis, the endocrine engine of linear growth, providing a plausible mechanistic bridge from a fecal-contaminated environment to a stunted child.

Meta-regression added a second layer of insight by identifying participant age and adjustment status as significant sources of between-study heterogeneity. The association between enteric infection and stunting was strongest among children younger than two years, which the authors read as a signal about the first 1000 days of life, the window from conception through roughly the second birthday during which linear growth velocity is highest and the developing gut and immune system are most vulnerable to disruption. This timing matters for intervention design. A child whose gut is repeatedly infected during the period of most rapid growth may sustain deficits that nutritional supplementation later in childhood cannot fully reverse, echoing longitudinal findings from the MAL-ED birth cohort across eight low- and middle-income country sites, which documented that even asymptomatic enteropathogen infections measurably depressed linear growth.

The finding that statistical adjustment for confounders shaped the observed effect estimates is equally important for readers interpreting the evidence. Observational studies of infection and stunting must contend with a dense thicket of confounding: household wealth, maternal education, water and sanitation access, breastfeeding practices, and diet all influence both infection risk and growth. Studies that adjusted more comprehensively for these factors produced different effect estimates than those that did not, and the meta-regression captured this as a source of heterogeneity. The very low GRADE rating applied to the pooled evidence reflects these inherent limitations. Association is not causation, reverse causality remains possible, since malnourished children may be more susceptible to infection as well as more harmed by it, and the Review authors are explicit that their pooled estimate should guide hypothesis formation and intervention priority-setting rather than be read as a precise causal coefficient.

The geographical scope of the underlying studies, spanning Ethiopia, Bangladesh, Indonesia, Peru, Zambia, Madagascar, the Philippines, Zimbabwe, and other low- and middle-income settings, underscores that the stunting–infection relationship is concentrated where sanitation infrastructure is weakest. Several included studies examined the interaction between enteric infections and environmental enteric dysfunction directly, and others evaluated how water, sanitation, and hygiene interventions perform in children carrying different pathogen burdens. Collectively, this literature suggests that the classic nutrition-centric framing of stunting, in which food insecurity is treated as the dominant driver, captures only part of the story. A child can consume adequate calories and still fail to grow if a chronically inflamed gut cannot absorb them.

For policymakers, the practical implications of the review are captured in its stated impact summary: the findings support integrating infection prevention, sanitation, and nutritional interventions into child stunting reduction programs, rather than pursuing these strategies in silos. That means pairing supplementary feeding and dietary diversification with safe water, improved sanitation, deworming where helminth burden is high, and, where available, vaccination against enteric pathogens. The absence of differences between pathogen domains complicates any pathogen-by-pathogen targeting strategy and instead argues for broad environmental measures that reduce exposure to the fecal–oral pathway as a whole. The vulnerability of children under two further suggests that interventions should begin in pregnancy and infancy, when the marginal return on preventing gut disruption is highest.

The review, published on 26 September 2026 with the DOI 10.1038/s41390-026-05520-4, arrives at a moment when the global health community is assessing why stunting prevalence has declined more slowly than under-five mortality. By quantifying a roughly twofold elevation in stunting odds associated with enteric infections across bacterial, viral, protozoal, and helminthic domains, and by flagging the first 1000 days as the period of maximal vulnerability, it offers both a synthesis of a fragmented literature and a clear agenda for what must come next: longitudinal studies with molecular diagnostics, better confounder control, and intervention trials that test whether breaking the infection–inflammation cycle unlocks growth that nutrition alone cannot deliver. The evidence may be graded very low in certainty, but the direction of the signal, and the scale of the population at risk, give it a weight that few will ignore.

Subject of Research: The association between enteric infections across four pathogen domains and childhood stunting in low- and middle-income countries

Article Title: Enteric infections and childhood stunting: a systematic review and meta-analysis across four pathogen domains

Article References: Pauzi, R. Y., Iqhrammullah, M., Ihtiaringtyas, S., Ilmi, A. N., Kumaratih, L. W., Yuliana, P. T., Aqila, R. A., & Raizma, E. Z. N. (2026). Enteric infections and childhood stunting: a systematic review and meta-analysis across four pathogen domains. Pediatric Research. https://doi.org/10.1038/s41390-026-05520-4

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05520-4

Keywords: childhood stunting, enteric infections, meta-analysis, systematic review, environmental enteric dysfunction, gut microbiology, pediatric growth, first 1000 days, soil-transmitted helminths, water sanitation and hygiene, low- and middle-income countries, GRADE evidence

The retracted paper, originally published on 19 May 2019 in Gut Pathogens under the title ‘Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (Cnf 1) in Escherichia coli: experimental and bioinformatics analyses,’ was authored by a team of Egyptian researchers working across two institutions. Radwa N. Morgan and Hala A. Farrag were affiliated with the Drug Radiation Research Department at the National Centre for Radiation Research and Technology, part of the Egyptian Atomic Energy Authority in Cairo, while Sarra E. Saleh and Mohammad M. Aboulwafa were based in the Microbiology and Immunology Department of the Faculty of Pharmacy at Ain Shams University, also in Cairo. Aboulwafa served as the corresponding author of the work.

The specific concerns documented in the retraction notice are detailed and methodical. Figure 1C and Figure 1F were found to partially overlap with each other, as were Figure 2C and Figure 2D. In addition, Figure 3D and Figure 3F showed partial overlap, and the two panels of Figure 6, panels a and b, also appeared to overlap. In each case, the overlapping images were supposed to depict different experimental conditions, meaning that identical or near-identical image regions had been used to represent results that should have been distinct. This pattern of duplication is one of the most common triggers for retractions in the scientific literature, because it undermines the reader’s ability to trust that the reported data were independently generated.

When such concerns are raised, the standard editorial process gives authors an opportunity to respond. In this instance, the retraction notice states plainly that the authors were unable to provide a satisfactory explanation or supporting data to address the concerns. Faced with unresolved questions about the integrity of the figures, the Editor-in-Chief concluded that the journal could no longer have confidence in the reliability of the research presented in the article, the formal threshold for a retraction under the guidelines that govern most scholarly publishers. Notably, the retraction is contested: Mohammad M. Aboulwafa has stated on behalf of all the authors that they disagree with the retraction. The retraction notice records this disagreement, which is standard practice, but a contested retraction still stands, and the article remains formally withdrawn from the scientific record.

The subject matter of the retracted study makes the retraction particularly relevant to researchers working on gut microbiology and bacterial pathogenesis. Colibactin is a genotoxin produced by certain strains of E. coli and related Enterobacteriaceae that live in the human gut. It is a polyketide-peptide hybrid molecule synthesized by enzymes encoded on the pks genomic island, and it works by cross-linking DNA in host cells. This DNA damage can trigger cell cycle arrest and cell death, and it has been implicated in the formation of characteristic mutational signatures found in colorectal cancer genomes. Because of this link to cancer biology, colibactin has been one of the most intensively studied bacterial toxins of the past decade, with laboratories around the world working to understand how it is produced, how it reaches host cells, and how its activity shapes the tumor microenvironment in the intestine.

Cytotoxic necrotizing factor 1, the second toxin examined in the retracted paper, is a different kind of weapon in the E. coli arsenal. Rather than damaging DNA, CNF1 is a bacterial protein toxin that permanently activates Rho GTPases, the molecular switches that control the actin cytoskeleton of host cells. By locking these switches in their active state, CNF1 causes dramatic cytoskeletal rearrangements, cell enlargement, and multinucleation, effects that contribute to tissue damage and inflammation. CNF1-producing strains are associated with urinary tract infections, meningitis, and other extraintestinal diseases, and the toxin has also been studied for its effects on epithelial barrier integrity and immune cell behavior. Studies of how prevalent these two virulence factors are in clinical and environmental E. coli populations, and what pathological effects they produce, sit squarely within the aims and scope of Gut Pathogens, which covers the microbiology, immunology, and pathogenesis of the gastrointestinal tract.

The retracted study combined laboratory experiments with bioinformatics analyses, an approach that has become increasingly common in microbiology as researchers pair phenotypic characterization of bacterial isolates with genomic and computational screening for virulence genes. Work of this kind typically involves collecting E. coli strains, testing them for the presence of toxin-encoding genes, measuring the pathological effects of toxin-producing isolates on cultured cells or model systems, and using computational tools to compare the genetic determinants of virulence across strains. Because such studies inform how scientists assess the disease potential of E. coli populations, retractions in this area matter to the wider field: findings that cannot be trusted may distort the perceived prevalence of dangerous toxin types or misdirect follow-up research.

The case also illustrates the ongoing evolution of post-publication peer review and image integrity screening. Journals and publishers increasingly use automated tools and expert forensic analysis to detect duplicated or manipulated images in published figures, and readers are encouraged to report concerns long after a paper’s publication date. The seven-year gap between the original publication in May 2019 and the retraction in September 2026 reflects the time such investigations can take, involving correspondence between the journal, the authors, and their institutions, and the careful documentation of specific figure-level concerns. The retraction notice itself is open access, ensuring that anyone who encounters the original paper through databases or citation trails will be directed to the notice explaining why the article was withdrawn.

For the research community, the practical consequences of a retraction are significant. The retracted article should no longer be cited as reliable evidence, and databases such as PubMed and the journal’s own website will flag it as retracted. The original article remains accessible online, as is standard practice, but it is watermarked and linked to the retraction notice so that readers understand its status. The authors’ disagreement with the retraction does not alter this status; the editorial decision rests on the journal’s judgment that the reliability of the findings cannot be assured. The retraction notice also notes that the article was published open access under a Creative Commons license, and Springer Nature’s standard publisher’s note regarding jurisdictional claims applies to the notice itself.

The broader lesson for microbiology and for science publishing is that the credibility of research on bacterial virulence factors depends on the integrity of the underlying experimental data. Colibactin and CNF1 remain genuine and important subjects of investigation, with well-documented roles in DNA damage, colorectal carcinogenesis, and cytoskeletal toxicity, and legitimate research on these toxins continues across many laboratories. Questions about the prevalence of toxin-producing E. coli strains and their pathological effects remain scientifically important, and they will be answered, as always, by studies whose figures, data, and analyses can withstand scrutiny. The retraction of this particular paper removes one unreliable data point from the literature while leaving the underlying scientific questions open for future, verifiable work.

Subject of Research: Retraction of a study on colibactin and cytotoxic necrotizing factor 1 production by Escherichia coli

Article Title: Retraction Note: Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor‑1 (Cnf 1) in Escherichia coli: experimental and bioinformatics analyses

Article References: Morgan, R. N., Saleh, S. E., Farrag, H. A., & Aboulwafa, M. M. (2026). Retraction Note: Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor‑1 (Cnf 1) in Escherichia coli: experimental and bioinformatics analyses. Gut Pathogens, 18(1), Article 75. https://doi.org/10.1186/s13099-026-00882-w

Image Credits: AI Generated

DOI: 10.1186/s13099-026-00882-w

Keywords: Escherichia coli, colibactin, CNF1, bacterial toxins, retraction, Gut Pathogens, research integrity, image duplication, gut microbiology, virulence factors, post-publication review, Springer Nature